Brainstem morphological changes in Alzheimer's disease

NeuroReport

Volumn 26, Issue 7, 2015, Pages 411-415

  Lee, Ji Han ^a   Ryan, John ^b   Andreescu, Carmen ^b   Aizenstein, Howard ^b   Lim, Hyun Kook ^c  

^a WASHINGTON UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c The Catholic University of Korea   (South Korea)

Author keywords

Alzheimer's disease; brainstem; MRI; shape analysis

Indexed keywords

AGED; ALZHEIMER DISEASE; ANTHROPOMETRIC PARAMETERS; ARTICLE; BRAIN SIZE; BRAIN STEM; BRAINSTEM SHAPE; CLINICAL ARTICLE; CLINICAL DEMENTIA RATING; CONTROLLED STUDY; FEMALE; HUMAN; INFERIOR COLLICULUS; MALE; MESENCEPHALON; MORPHOLOGY; PRIORITY JOURNAL; AGING; IMAGE PROCESSING; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN SIZE; PATHOLOGY; PSYCHOLOGICAL RATING SCALE;

AGED; AGING; ALZHEIMER DISEASE; BRAIN STEM; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; ORGAN SIZE; PSYCHIATRIC STATUS RATING SCALES;

EID: 84928345943     PISSN: 09594965     EISSN: 1473558X     Source Type: Journal    
DOI: 10.1097/WNR.0000000000000362     Document Type: Article

References (25)

1. Hahn C, Lim HK, Won WY, Ahn KJ, Jung WS, Lee CU. Apathy and white matter integrity in Alzheimer's disease: a whole brain analysis with tractbased spatial statistics. PLoS One 2013; 8:e53493.
2. Grinberg LT, Rueb U, Heinsen H. Brainstem: neglected locus in neurodegenerative diseases. Front Neurol 2011; 2:42.
3. Montplaisir J, Petit D, Lorrain D, Gauthier S, Nielsen T. Sleep in Alzheimer's disease: further considerations on the role of brainstem and forebrain cholinergic populations in sleep-wake mechanisms. Sleep 1995; 18:145-148.
4. Rub U, del Tredici K, Schultz C, Thal DR, Braak E, Braak H. The autonomic higher order processing nuclei of the lower brain stem are among the early targets of the Alzheimer's disease-related cytoskeletal pathology. Acta Neuropathol 2001; 101:555-564.
5. Simic G, Stanic G, Mladinov M, Jovanov-Milosevic N, Kostovic I, Hof PR. Does Alzheimer's disease begin in the brainstem? Neuropathol Appl Neurobiol 2009; 35:532-554.
6. Patenaude B, Smith SM, Kennedy DN, Jenkinson M. A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage 2011; 56:907-922.
7. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34:939-944.
8. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993; 43:2412-2414.
9. Lee JH, Lee KU, Lee DY, Kim KW, Jhoo JH, Kim JH, et al. Development of the Korean version of the Consortium to Establish a Registry for Alzheimer's Disease Assessment Packet (CERAD-K): clinical and neuropsychological assessment batteries. J Gerontol B Psychol Sci Soc Sci 2002; 57: P47-P53.
10. Smith SM, Zhang Y, Jenkinson M, Chen J, Matthews PM, Federico A, de Stefano N. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 2002; 17:479-489.
11. Ashburner J, Csernansky JG, Davatzikos C, Fox NC, Frisoni GB, Thompson PM. Computer-Assisted imaging to assess brain structure in healthy and diseased brains. Lancet Neurol 2003; 2:79-88.
12. Naidich TP, Duvernoy HM, Delman BN, Sorensen AG, Kollias SS, Haacke EM. Duvernoy's Atlas of the human brain stem and cerebellum. Vienna, Austria: Springer; 2008.
13. Jack CR Jr, Albert MS, Knopman DS, McKhann GM, Sperling RA, Carrillo MC, et al. Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7:257-262.
14. Parvizi J, Van Hoesen GW, Damasio A. The selective vulnerability of brainstem nuclei to Alzheimer's disease. Ann Neurol 2001; 49:53-66.
15. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991; 82:239-259.
16. Hardy JA, Mann DM, Wester P, Winblad B. An integrative hypothesis concerning the pathogenesis and progression of Alzheimer's disease. Neurobiol Aging 1986; 7:489-502.
17. Ramon-Moliner E, NautaWJ. The isodendritic core of the brain stem. J Comp Neurol 1966; 126:311-335.
18. Insausti R, Amaral DG, Cowan WM. The entorhinal cortex of the monkey: III. Subcortical afferents. J Comp Neurol 1987; 264:396-408.
19. Grinberg LT, Rub U, Ferretti RE, Nitrini R, Farfel JM, Polichiso L, et al. Brazilian Brain Bank Study Group. The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset? Neuropathol Appl Neurobiol 2009; 35:406-416.
20. Zweig RM, Ross CA, Hedreen JC, Steele C, Cardillo JE, Whitehouse PJ, et al. The neuropathology of aminergic nuclei in Alzheimer's disease. Ann Neurol 1988; 24:233-242.
21. Mann DM, Yates PO, Marcyniuk B. Changes in Alzheimer's disease in the magnocellular neurones of the supraoptic and paraventricular nuclei of the hypothalamus and their relationship to the noradrenergic deficit. Clin Neuropathol 1985; 4:127-134.
22. Bondareff W, Mountjoy CQ, Roth M, Rossor MN, Iversen LL, Reynolds GP. Age and histopathologic heterogeneity in Alzheimer's disease. Evidence for subtypes. Arch Gen Psychiatry 1987; 44:412-417.
23. Zubenko GS, Moossy J, Kopp U. Neurochemical correlates of major depression in primary dementia. Arch Neurol 1990; 47:209-214.
24. Albert MS, deKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7:270-279.
25. Rowe CC, Ng S, Ackermann U, Gong SJ, Pike K, Savage G, et al. Imaging beta-Amyloid burden in aging and dementia. Neurology 2007; 68:1718-1725.